Do drug-eluting stents reduce the composite outcome of death from any cause and nonfatal spontaneous myocardial infarction compared to bare-metal stents in patients undergoing PCI?
Patients undergoing percutaneous coronary intervention (PCI)
Drug-eluting stents
Bare-metal stents
Composite outcome of death from any cause and nonfatal spontaneous myocardial infarctioncomposite
Drug-eluting stents reduce the need for repeat revascularization compared to bare-metal stents, without a significant difference in hard clinical outcomes like death or myocardial infarction.
In patients undergoing PCI, there were no significant differences between those receiving drug-eluting stents and those receiving bare-metal stents in the composite outcome of death from any cause and nonfatal spontaneous myocardial infarction. Rates of repeat revascularization were lower in the group receiving drug-eluting stents. (Funded by the Norwegian Research Council and others; NORSTENT ClinicalTrials.gov number, NCT00811772 .).
Building similarity graph...
Analyzing shared references across papers
Loading...
Kaare Harald Bønaa
Jan Mannsverk
Rune Wiseth
New England Journal of Medicine
Norwegian Womens Public Health Association
Building similarity graph...
Analyzing shared references across papers
Loading...
Bønaa et al. (Tue,) studied this question.
www.synapsesocial.com/papers/69dbcb9437b5141e3ba3d46e — DOI: https://doi.org/10.1056/nejmoa1607991